<DOC>
	<DOCNO>NCT01233999</DOCNO>
	<brief_summary>The investigator study medical condition know Raynaud 's Phenomenon ( RP ) . RP painful condition cold surroundings stressful event trigger pain , cold sensation , severe case , sores ulcer one 's finger . The investigator think RP result problem component blood vessel , surround nerve , circulate messenger bloodstream . Although many different medicine currently use treat RP , investigator yet find cure severe case condition . Furthermore , investigator find medicine show consistent heal ulcer may associate RP . Some treatment include medicine use treat high blood pressure know calcium channel blocker . Medications thin blood ( anticoagulant ) aspirin also use treat RP . In study , investigator investigate new treatment RP know Botulinum toxin A. Botulinum toxin chemical temporarily toxic nerve , approve government treatment several condition include limited : excessive sweating , neck pain associate condition know cervical dystonia , uncontrollable forcible closure eyelid know blepharospasm , condition know strabismus eye alignment one another . This study aim greatly improve quality life pain associate RP . Previous study also support chance Botulinum toxin help heal ulcer associate RP . Although current standard care , many patient study already fail unable tolerate commonly use treatment lifestyle modification , calcium channel blocker , nitroglycerin , anticoagulant . If patient chooses participate study , he/she randomly assign receive injection Botulinum toxin either leave right hand . The hand inject saline solution . Neither patient physician research personnel see follow-up know hand inject Botulinum toxin .</brief_summary>
	<brief_title>Botulinum Toxin Treatment Raynaud 's</brief_title>
	<detailed_description />
	<mesh_term>Raynaud Disease</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Adult ( &gt; 18 year ) patient severe RP etiology invite participate . Inclusion criterion include ) history digital infarct ulceration , b ) unresponsive standard therapy , c ) impend potential digital amputation . Patients standard therapy antiplatelet agent , vasodilator , calcium channel blocker include . Pregnancy , mild disease , patient myasthenia gravis , botulinum toxin allergy , phobia needle exclusion criterion . Women childbearing age need demonstrate negative urine pregnancy test . Myasthenia gravis exclude underlie generalized weakness exacerbate , local weakness injection sit occur otherwise expect .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Scleroderma</keyword>
	<keyword>Raynaud 's Syndrome</keyword>
</DOC>